Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Visible Weight Loss : By 8-12 weeks, most patients begin to see more noticeable weight loss
Monitoring and Follow-up A medically supervised approach varies but typically includes: A health history review and contraindication screening (including thyroid cancer history and MEN2 risk) A plan for dose titration and side-effect management Periodic check-ins to assess progress, appetite changes, tolerability, and adherence Monitoring of vitals and labs when clinically appropriate, especially if you have diabetes or take other glucose-lowering medications Other Medications and Interactions Tell your clinician about all prescription medications, over-the-counter products, and supplements you take
Since the first GLP-1R agonist, exenatide, was approved for the treatment of T2DM in 2005, a variety of GLP-1R agonists such as liraglutide and dulaglutide have been approved
Nutrients (2022) 14:3338
